19 June 2013
Keywords: fda, clears, new, strengths, novartis, stalevo, swiss
Article | 03 November 2008
Swiss drug major Novartis says the US Food and Drug Administration has approved two new dose strengths of Parkinson's disease ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 November 2008
© 2013 thepharmaletter.com